HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro

J Biol Chem. 2007 Mar 16;282(11):8005-10. doi: 10.1074/jbc.M608274200. Epub 2006 Dec 15.

Abstract

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. NNRTIs inhibit reverse transcription in a substrate length-dependent manner in biochemical assays and in cell-based HIV-1 replication assays, suggesting a stochastic inhibitory mechanism. Surprisingly, we observed that NNRTIs potently inhibited plus-strand initiation in vitro under conditions in which little or no inhibition of minus-strand DNA synthesis was observed. In assays that recapitulated the initiation of plus-strand DNA synthesis, greater inhibition was observed with an RNA PPT primer than with a DNA primer of corresponding sequence and with wild-type reverse transcriptase but not with NNRTI-resistant enzymes. Structural elements that dictate sensitivity to NNRTIs were revealed using modified plus-strand initiation substrates. The data presented here suggest that specific inhibition of plus-strand initiation may be an important mechanism by which NNRTIs block HIV-1 replication.

MeSH terms

  • Alkynes
  • Anti-HIV Agents / pharmacology
  • Benzoxazines
  • Benzoxazoles / pharmacology
  • Cyclopropanes
  • DNA / chemistry
  • Dose-Response Relationship, Drug
  • Drug Resistance, Viral*
  • Enzyme Inhibitors / pharmacology
  • HIV Reverse Transcriptase / metabolism*
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Ligands
  • Models, Genetic
  • Oxazines / pharmacology
  • Pyridones / pharmacology
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Stochastic Processes
  • Transcription, Genetic
  • Virus Replication

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Benzoxazoles
  • Cyclopropanes
  • Enzyme Inhibitors
  • Ligands
  • Oxazines
  • Pyridones
  • Reverse Transcriptase Inhibitors
  • L-697661
  • DNA
  • HIV Reverse Transcriptase
  • efavirenz